Literature analysis and research progress on radiation-induced heart injury in China
10.3760/cma.j.cn113030-20220927-00324
- VernacularTitle:放射性心脏损伤国内相关文献分析及研究进展
- Author:
Ruimin HAN
1
;
Chao WU
;
Hongjuan YANG
;
Feng WANG
;
Lixin WANG
;
Yunchuan SUN
Author Information
1. 河北省沧州中西医结合医院放疗科，沧州 061000
- Keywords:
Neoplasms;
Radiotherapy;
Radiation-induced heart injury;
Literature research;
Animal experiment;
Clinical research
- From:
Chinese Journal of Radiation Oncology
2023;32(9):805-811
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the research status and comment of radiation-induced heart injury based on relevant literature analysis in China.Methods:A literature database was established with studies published from 1983 to 2021 as the data source from "China National Knowledge Infrastructure (CNKI) database", "Wanfang Database", "VIP Chinese Science and Technology Journal Database" and "China Biology Medicine Disc". The publication date, type and journal distribution of studied related to radiation-induced heart injury were quantitatively analyzed.Results:A total of 300 literatures were included. The chronological distribution of literatures: from 1983 to 2021, the number of literatures related to radiation-induced heart injury was gradually increased, and the overall trend was on the rise. The top three publication journals were Chinese Journal of Radiation Oncology, Chinese Journal of Radiation Medicineand Protection, and Chinese Journal of Cancer Prevention and Treatment. Literature type distribution: clinical research accounted for 48.50%, 25.58% for review, and 17.61% for animal experiment, respectively. The distribution of clinical research types: lung cancer, esophageal cancer and breast cancer were the most, followed by thymoma and lymphoma. In animal experiments, rat was the most frequently studied animal model, and the maximum radiation dose was 20 Gy. Conclusions:The number of studies related to radiation-induced heart injury is gradually increasing in China. The quantity of clinical studies is higher than that of animal experiments, most clinical studies focus on chest tumors, but there is great potential in animal experimental research. We still need to explore the pathogenesis of radiation-induced heart injury and develop drug prevention and intervention strategies.
